This could be because people are scrutinising the appearance of their feet less than other parts of their body, such as the face or neck, or, as Dr Esho puts it, patients may not connect the dots between their foot discomfort and their weight loss treatment
Studies of dual GIP/GLP-1 agonists reported TBW (40.0%) and weight loss proportions (40.0%)
Vitamin B12 combinations have the strongest theoretical rationale (GLP-1 agonists may slow B12 absorption over time
During the study, researchers investigated whether individuals with tobacco use disorder who were on any of these antidiabetic medications received prescriptions for smoking cessation or were referred to counseling during their medical visits
[DOI] [PubMed] [Google Scholar] 17.Morikawa T., Munekata E., Sakakibara S., Noda T., Otani M